Assesment of Olfactory Disorders and Performance of a New Olfactory Test in Children With Congenital CMV
NCT02782988 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 106
Last updated 2021-07-27
Summary
CMV lesions were found in the olfactory system of children with congenital CMV infection but no study has hitherto examined the impact of congenital CMV infection on olfaction. So the investigators propose in this study to assess the proportion of children with olfactory deficits among children with congenital CMV infection. Second this study will also evaluate performances of a new olfactory test, based on discrimination of binary odorant mixtures.
Conditions
- Congenital Cytomegalovirus Infection
Interventions
- OTHER
-
olfactory tests, otoacoustic emissions (OAE)
Two series of olfactory tests will be performed : 1) the first one with simple odorants and 2) the second one with binary mixtures of odorants. These tests of nasal chemosensory performance are based on pen-like odor dispensing devices (Sniffin' Sticks, Burghardt, Wedel, Germany) and measure odor discrimination ability of young children in less than 15 min.
Sponsors & Collaborators
-
Institut Pasteur
lead INDUSTRY
Principal Investigators
-
Françoise LAZARINI, PhD · Institut Pasteur, Paris France
Eligibility
- Min Age
- 3 Years
- Max Age
- 10 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-05-31
- Primary Completion
- 2020-05-02
- Completion
- 2020-05-02
Countries
- France
Study Locations
More Related Trials
-
Genotyping of Cytomegalovirus From Patients in Israel
NCT00228202 ·Status: UNKNOWN
-
Cell Mediated Immunity for Secondary Prophylaxis in CMV SOT Patients
NCT02370758 ·Status: COMPLETED ·Phase: NA
-
Cytomegalovirus Testing and Intervention Protocol for Newborn Nursery and Newborn Intensive Care Unit
NCT02680743 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Software for Interpreting Virological Results Indicated for the Diagnosis of Cytomegalovirus (CMV) Infection During Pregnancy and Intended for Health Professionals
NCT06694428 ·Status: RECRUITING
-
Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss
NCT01649869 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Safety and Immune Responses of the Towne Strain of CMV in Seronegative Women
NCT00201448 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Study on Cytomegalovirus (CMV) Infection Outcomes Among Hematopoietic Stem Cell Transplant (HSCT) Participants in Europe and Canada
NCT05571137 ·Status: COMPLETED
-
Cytomegalovirus Cell-Mediated Immunity
NCT00815165 ·Status: COMPLETED
-
A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes
NCT00001062 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of Four Chimera Cytomegalovirus (CMV) Vaccines in Healthy Adult Males 30-50 Years of Age
NCT01195571 ·Status: COMPLETED ·Phase: PHASE1
-
Cytomegalovirus (CMV) Vaccines: Reinfection and Antigenic Variation
NCT03443791 ·Status: COMPLETED ·Phase: NA
-
A French Cohort of Transplant Recipients With CMV Infection : Risk Factors for Antiviral Resistance in the Prophylaxis Era.
NCT02067169 ·Status: COMPLETED
-
AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients
NCT04690933 ·Status: COMPLETED
-
Development of Potential Biomarkers for Foetal Brain Development After Congenital CMV Infection
NCT03188679 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection
NCT01602614 ·Status: COMPLETED
-
Natural History of Cytomegalovirus (CMV) Infection and Disease Among Renal Transplant Recipients
NCT01833416 ·Status: COMPLETED
-
Clinical Performance Evaluation of DxN CMV Assay
NCT03127787 ·Status: TERMINATED
-
Clinical and Immunological Features of the CMV Infection Atypical Course in Immunocompetent Individuals
NCT04392297 ·Status: COMPLETED
-
A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus
NCT06118515 ·Status: RECRUITING ·Phase: PHASE1
-
Detection of Cytomegalovirus Virus in Neonates
NCT03251261 ·Status: COMPLETED
-
Treatment of Low Dose IL-2 and Ganciclovir in Cytomegalovirus Infection
NCT04225780 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections
NCT00466817 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Adolescent Females to Explore Cytomegalovirus Infection
NCT01691820 ·Status: COMPLETED ·Phase: NA
-
Asymptomatic Congenital CMV Treatment
NCT03301415 ·Status: TERMINATED ·Phase: PHASE2
-
Cytomegalovirus (CMV) Perilymphatic Fluid
NCT04724265 ·Status: UNKNOWN ·Phase: NA